Back to search

Article

Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic study

2026-06-25

Abstract excerpt

<title>Abstract</title> <p> Background Metabolic-associated fatty liver disease (MAFLD) is a common chronic liver disease characterized by hepatic lipid accumulation and impaired fatty acid metabolism. Increasing evidence suggests that disruption of the SIRT1/PGC-1α/PPARα signaling pathway contributes to abnormal fatty acid β-oxidation and disease progression. This study aimed to explore the role of liraglutide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
010441d8-5aa9-5672-9540-c181f8f019ef
DOI
10.21203/rs.3.rs-9999800/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic studyDOI 10.21203/rs.3.rs-9999800/v1
The Role of TM6SF2 in Non-Alcoholic Fatty Liver Disease: From Mechanisms To Therapeutic StrategySemantic proximity
Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity
Tirzepatide but not Semaglutide Ameliorates Hepatic Steatosis and Inflammatory Infiltration in a Mouse Model of MASLD via Inhibition of the CCL2/CCR2-PI3K-Akt PathwaySemantic proximity
Identification of Fatty acid metabolism-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Nonalcoholic fatty liver diseaseSemantic proximity
Enpp1 ameliorates NAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathwaySemantic proximity
Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implicationsSemantic proximity
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic StrategiesSemantic proximity
The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease Through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq TranscriptomicsSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental studySemantic proximity
Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancerSemantic proximity
The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic targetSemantic proximity
Select a neighboring publication to make it the new centre.